Tadalafil Cipla 5 mg, 20 mg FC tablets
PDF Leaflet Revision Date: 16 January 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of erectile dysfunction.
Dosage (summary)
5 mg once daily; max 20 mg before sexual activity.
Onset of Action / Duration
Onset: 16 mins, Duration: up to 36 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not indicated for women; not safe during pregnancy or breastfeeding.
Key Drug Interactions
- Nitrates
- CYP3A4 inhibitors
- Alpha1 blockers
Contraindications
- Hypersensitivity to tadalafil
- Severe hepatic insufficiency
- Use with organic nitrates
Common side effects
- Headache
- Dyspepsia
- Back pain
- Myalgia
Counselling Points
- Take at the same time daily
- Avoid use with nitrates
- Seek help for prolonged erections
Serious warnings
- Risk of hypotension with nitrates
- NAION risk
- Priapism
Important Disclaimer
The Tadalafil Cipla 5 mg, 20 mg FC tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
